drug
Pliaglis
Marketedupdated 4mo agoby Taro Pharmaceutical USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 14, 2031
~4.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Jan 14, 2031formulationUS 103501804.4y
- Jan 14, 2031formulationUS 106032934.4y
- Jan 14, 2031formulationUS 107513054.4y
- Jan 14, 2031method-of-use (U-4421)US 125583284.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that